Chemotherapy linked to physical decline in older women with high-risk breast cancer

FHS
May 11, 2024
1:47 am

A UCLA-led study suggests women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function.

Pharmalittle: We’re reading about drug price hikes, Bayer strategic moves, and more

Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are hovering over the Pharmalot campus right now, but our spirits

January 18, 2024

GSK to acquire Chimagen’s CMG1A46 for autoimmune treatment

The acquisition of CMG1A46 is a strategic move to address the diverse manifestations of lupus and the ongoing burden it places on patients. Credit: Indypendenz/Shutterstock.

October 30, 2024

Fluoride at Twice the Recommended Limit Tied to Lower IQ in Kids, U.S. Report Says

A U.S. government report expected to stir debate concluded that fluoride in drinking water at twice the recommended limit is linked with lower IQ in

August 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.